Innocoll: Innocoll Appoints Louis Pascarella as CEO
Innocoll Holdings Limited, a specialty pharmaceutical company wholly owned by Gurnet Point Capital, a private investment firm focused on health care, today announced that Louis Pascarella
Read full article »
Innocoll is a New Jersey-based biotech pharmaceutical company that researches and develops collagen-infused medicinal products for postsurgical pain management.
Read more